Compare Stocks: ZTS vs. VTRS vs. PBH vs. IRWD
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
ZTSVTRSPBHIRWD
Market Snapshot
Current market context for the selected companies.
ZTS
$77.25
Market Cap
$32.12B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Data through
2026-08-24
VTRS
$16.46
Market Cap
$18.75B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Data through
2026-08-24
PBH
$51.81
Market Cap
$2.43B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Data through
2026-08-24
IRWD
$4.18
Market Cap
$708.88M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Data through
2026-08-24
Performance
Absolute returns and relative performance versus SPY.
| Metric | ZTS | VTRS | PBH | IRWD |
|---|---|---|---|---|
| 1 Month | +2.5% | -4.5% | +4.3% | +12.7% |
| 1 Month vs SPY | -0.9% | -7.9% | +1.0% | +9.3% |
| 3 Months | -5.0% | -1.1% | +7.9% | +6.6% |
| 3 Months vs SPY | -7.5% | -3.6% | +5.5% | +4.2% |
| 6 Months | -38.6% | +3.2% | -25.6% | +11.5% |
| 6 Months vs SPY | -50.5% | -8.7% | -37.6% | -0.5% |
| 1 Year | -50.4% | +54.0% | -20.8% | +254.2% |
| 1 Year vs SPY | -70.6% | +33.8% | -41.0% | +234.0% |
| 2 Years | -58.1% | +39.2% | -25.2% | -12.2% |
| 2 Years vs SPY | -94.6% | +2.7% | -61.7% | -48.7% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.